Previous studies showed that the IDO1 inhibitor 1-MT (L or D stereoisomer) could not prolong GL261 orthotopic glioma mouse survival time.28–30 TDO inhibitors have not been tested in glioma animals. The gene discussed is TDO2; the disease is central nervous system cancer.